1. Home
  2. FATE vs ARIS Comparison

FATE vs ARIS Comparison

Compare FATE & ARIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • ARIS
  • Stock Information
  • Founded
  • FATE 2007
  • ARIS 2015
  • Country
  • FATE United States
  • ARIS United States
  • Employees
  • FATE N/A
  • ARIS N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • ARIS Water Supply
  • Sector
  • FATE Health Care
  • ARIS Utilities
  • Exchange
  • FATE Nasdaq
  • ARIS Nasdaq
  • Market Cap
  • FATE 406.5M
  • ARIS 470.1M
  • IPO Year
  • FATE 2013
  • ARIS 2021
  • Fundamental
  • Price
  • FATE $2.02
  • ARIS $23.93
  • Analyst Decision
  • FATE Buy
  • ARIS Strong Buy
  • Analyst Count
  • FATE 11
  • ARIS 7
  • Target Price
  • FATE $6.89
  • ARIS $19.71
  • AVG Volume (30 Days)
  • FATE 1.6M
  • ARIS 554.8K
  • Earning Date
  • FATE 11-12-2024
  • ARIS 11-04-2024
  • Dividend Yield
  • FATE N/A
  • ARIS 1.75%
  • EPS Growth
  • FATE N/A
  • ARIS 67.78
  • EPS
  • FATE N/A
  • ARIS 0.81
  • Revenue
  • FATE $13,447,000.00
  • ARIS $420,960,000.00
  • Revenue This Year
  • FATE N/A
  • ARIS $10.64
  • Revenue Next Year
  • FATE N/A
  • ARIS $8.00
  • P/E Ratio
  • FATE N/A
  • ARIS $29.59
  • Revenue Growth
  • FATE N/A
  • ARIS 13.51
  • 52 Week Low
  • FATE $1.96
  • ARIS $7.22
  • 52 Week High
  • FATE $8.83
  • ARIS $26.34
  • Technical
  • Relative Strength Index (RSI)
  • FATE 31.10
  • ARIS 73.47
  • Support Level
  • FATE $2.33
  • ARIS $16.12
  • Resistance Level
  • FATE $2.58
  • ARIS $26.34
  • Average True Range (ATR)
  • FATE 0.25
  • ARIS 1.29
  • MACD
  • FATE -0.04
  • ARIS 0.65
  • Stochastic Oscillator
  • FATE 6.45
  • ARIS 78.29

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About ARIS Aris Water Solutions Inc.

Aris Water Solutions Inc is an environmental infrastructure and solutions company that helps customers reduce their water and carbon footprints. It has two primary revenue streams. The Produced Water Handling business gathers, transports, and, unless recycled, handles produced water generated from oil and natural gas production. The Water Solutions business develops and operates recycling facilities to treat, store and recycle produced water.

Share on Social Networks: